Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 19/10/2018
SIETES contiene 92571 citas

 1 a 20 de 175 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Tsai W-C, Wu H-Y, Peng Y-S, Yang J-Y, Chen HY, Chiu Y-L, Hsu S-P, Ko M-J, Pai M-F, Tu Y-K, Hung K-Y, Chien K-L. Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: a systematic review and meta-analysis. JAMA Intern Med 2017;177:792-9. [Ref.ID 101619]
3.Enlace a cita originalTiene citas relacionadas Cita con resumen
Hoes AW. ß blockers for heart failure. BMJ 2016;352:i2074. [Ref.ID 100195]
4.Tiene citas relacionadas Cita con resumen
Bolen SD, Maruthur NM. The safety of incretin based drug treatments for type 2 diabetes. BMJ 2016;352:i801. [Ref.ID 100062]
5. Cita con resumen
Anónimo. FDA declines application for DMD drug as insufficient. DIA Daily 2016:4. [Ref.ID 100013]
6. Cita con resumen
D'Amico AV, Chen M-H, Renshaw A, Loffredo M, Kantoff PW. Long-term follow-up of a randomized trial of radiation with or without androgen deprivation therapy for localized prostate cancer. JAMA 2015;314:1291-3. [Ref.ID 99525]
7. Cita con resumen
Benetos A, Rossignol P, Cherubini A, Joly L, Grodzicki T, Rajkumar C, Strandberg TE, Petrovic M. Polypharmacy in the aging patient: management of hypertension in octogenarians. JAMA 2015;314:170-80. [Ref.ID 99347]
8. Cita con resumen
Pryce G, Baker D. Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis. Evid Based Med 2015;20:124. [Ref.ID 99261]
9.Tiene citas relacionadas Cita con resumen
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Ismail HIHM, Reynales H, Limkittikul K, Rivera-Medina HN, Bouchenooghe TA, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M, for the CYD-TDV Dengue Vaccine Working Group. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med 2015;373:1195-206. [Ref.ID 99178]
11.Tiene citas relacionadas
McNully SJ, Williams P. Bad medicine: surrogate markers. BMJ 2014;348:g2012. [Ref.ID 97418]
12.Tiene citas relacionadas Cita con resumen
Braillon A. Example of junk evaluation by the European Medicines Agency. BMJ 2014;348:g2017. [Ref.ID 97417]
13. Cita con resumen
Anónimo. Pertuzumab. Prescrire 2013;33:816. [Ref.ID 96493]
14.Tiene citas relacionadas Cita con resumen
Gagne JJ, Bykov K, Choudhry NK, Toomey TJ, Connolly JG, Avorn J. Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ 2013;347:11. [Ref.ID 96346]
15.Tiene citas relacionadas Cita con resumen
Hirschl MM. Smoking status and the effects of antiplatelet drugs. BMJ 2013;347:10. [Ref.ID 96345]
16.Tiene citas relacionadas
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran DJ, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzylio W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL. Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial. Lancet 2013;382:605-13. [Ref.ID 96025]
17.Tiene citas relacionadas
Swaminathan RV, Feldman DN. TRILOGY ACS: prasugrel of benefit only after angiography?. Lancet 2013;382:580-2. [Ref.ID 96024]
18. Cita con resumen
Mahaffey KW, Wojdyla D, Hankey GJ, White HD, Nessel CC, Piccini JP, Patel MR, Berkowitz SD, Becker RC, Halperin JL, Singer DE, Califf RM, Fox KAA, Breithardt G, Hacke W. Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial. Ann Intern Med 2013;158:861-8. [Ref.ID 95680]
19. Cita con resumen
Grodstein F, O'Brien J, Kang JH, Dushkes R, Cook NR, Okereke O, Manson JE, Glynn RJ, Buring JE, Gaziano M, Sesso HD. Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med 2013;159:806-14. [Ref.ID 94654]
20. Cita con resumen
VanderWeele TJ, Knol MJ. Interpretation of subgroup analyses in randomized trials: heterogeneity vesus secondary interventions. Ann Intern Med 2011;154:680-3. [Ref.ID 91284]
Seleccionar todas
 1 a 20 de 175 siguiente >>